POSOCCO, BIANCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.017
AS - Asia 1.904
EU - Europa 688
SA - Sud America 297
AF - Africa 272
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 11
Totale 5.210
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.847
SG - Singapore 602
VN - Vietnam 469
CN - Cina 321
BR - Brasile 195
HK - Hong Kong 144
DE - Germania 103
IT - Italia 87
FI - Finlandia 77
FR - Francia 53
IN - India 45
PL - Polonia 39
GB - Regno Unito 36
RU - Federazione Russa 36
CA - Canada 33
BD - Bangladesh 27
TR - Turchia 27
AR - Argentina 23
NL - Olanda 23
PK - Pakistan 22
ZA - Sudafrica 22
MX - Messico 19
UA - Ucraina 19
EC - Ecuador 18
SA - Arabia Saudita 18
AT - Austria 17
JP - Giappone 17
IQ - Iraq 16
KR - Corea 16
ID - Indonesia 15
PY - Paraguay 15
SE - Svezia 15
CO - Colombia 14
GE - Georgia 13
MA - Marocco 13
DK - Danimarca 12
HN - Honduras 12
BJ - Benin 11
CL - Cile 11
EG - Egitto 11
GT - Guatemala 11
HR - Croazia 10
KG - Kirghizistan 10
NI - Nicaragua 10
RO - Romania 10
AL - Albania 9
AO - Angola 9
BB - Barbados 9
IE - Irlanda 9
JO - Giordania 9
LV - Lettonia 9
ML - Mali 9
SN - Senegal 9
TH - Thailandia 9
YT - Mayotte 9
AD - Andorra 8
BA - Bosnia-Erzegovina 8
CV - Capo Verde 8
GN - Guinea 8
LA - Repubblica Popolare Democratica del Laos 8
MG - Madagascar 8
MY - Malesia 8
NP - Nepal 8
PH - Filippine 8
PT - Portogallo 8
RE - Reunion 8
BF - Burkina Faso 7
BY - Bielorussia 7
CG - Congo 7
CI - Costa d'Avorio 7
CW - ???statistics.table.value.countryCode.CW??? 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
GM - Gambi 7
IL - Israele 7
LU - Lussemburgo 7
MD - Moldavia 7
PS - Palestinian Territory 7
TT - Trinidad e Tobago 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
BZ - Belize 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
ES - Italia 6
ET - Etiopia 6
GP - Guadalupe 6
GR - Grecia 6
IR - Iran 6
KE - Kenya 6
LT - Lituania 6
LY - Libia 6
MK - Macedonia 6
MN - Mongolia 6
MR - Mauritania 6
NA - Namibia 6
NZ - Nuova Zelanda 6
PA - Panama 6
PE - Perù 6
PR - Porto Rico 6
Totale 4.960
Salva come PNG Salva come JPEG
Città #
Singapore 408
Ashburn 404
San Jose 318
Ho Chi Minh City 154
Hanoi 137
Hong Kong 133
Fairfield 104
Chandler 85
Beijing 83
Munich 68
Santa Clara 60
Houston 47
New York 42
Cambridge 41
Seattle 41
Ann Arbor 40
Helsinki 38
Los Angeles 36
Boardman 34
Woodbridge 34
Bytom 29
Lauterbourg 27
Wilmington 27
Buffalo 24
Da Nang 22
São Paulo 22
Turku 21
San Diego 19
Chicago 18
Dallas 16
Guangzhou 15
Medford 14
Princeton 14
London 13
Orem 13
Haiphong 12
Hefei 12
Montreal 12
Tokyo 12
Cotonou 11
Council Bluffs 11
Johannesburg 11
Toronto 11
Chennai 10
Managua 10
Milan 10
Vienna 10
Bishkek 9
Bridgetown 9
Bến Tre 9
Falkenstein 9
Jeddah 9
Lahore 9
Amman 8
Andorra la Vella 8
Biên Hòa 8
Brooklyn 8
Conakry 8
Dakar 8
Guayaquil 8
Hải Dương 8
Kyiv 8
Riga 8
Rio de Janeiro 8
Trieste 8
Amsterdam 7
Ankara 7
Baghdad 7
Cairo 7
Des Moines 7
Luanda 7
Minsk 7
Praia 7
San Francisco 7
Tirana 7
Abidjan 6
Baku 6
Bamako 6
Brazzaville 6
Copenhagen 6
Frankfurt am Main 6
Guatemala City 6
Kampala 6
Kigali 6
Lappeenranta 6
Luxembourg 6
Nairobi 6
Nha Trang 6
Ninh Bình 6
Nouakchott 6
Panama City 6
Thái Bình 6
Ulan Bator 6
Vientiane 6
Auckland 5
Boston 5
Cape Town 5
Castries 5
Charlotte 5
Dili 5
Totale 3.097
Salva come PNG Salva come JPEG
Nome #
Field-assisted paper spray mass spectrometry for therapeutic drug monitoring: 1. the case of imatinib in plasma 244
Cross-validation of a mass spectrometric-based method for the therapeutic drug monitoring of irinotecan: implementation of matrix-assisted laser desorption/ionization mass spectrometry in pharmacokinetic measurements 222
A new high-performance liquid chromatography–tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine 219
A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer 212
NPQ activation reduces chlorophyll triplet state formation in the moss Physcomitrella patens 203
Light driven water oxidation by a single site cobalt salophen catalyst 202
A LC–MS/MS method for therapeutic drug monitoring of sorafenib, regorafenib and their active metabolites in patients with hepatocellular carcinoma 197
Analytical aspects of sunitinib and its geometric isomerism towards therapeutic drug monitoring in clinical routine 183
Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug-gene interactions 182
Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application 182
An SPR investigation into the therapeutic drug monitoring of the anticancer drug imatinib with selective aptamers operating in human plasma 180
Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients 179
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure 175
Dried Blood Spot Technique Applied in Therapeutic Drug Monitoring of Anticancer Drugs: a Review on Conversion Methods to Correlate Plasma and Dried Blood Spot Concentrations 172
Field-assisted paper spray mass spectrometry for the quantitative evaluation of imatinib levels in plasma 168
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer 165
Bioanalytical Methods for Poly(ADP-Ribose) Polymerase Inhibitor Quantification: A Review for Therapeutic Drug Monitoring 165
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer 161
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis 161
A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring 160
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure 158
A new LC-MS/MS method for the simultaneous quantification of abemaciclib, its main active metabolites M2 and M20, and letrozole for therapeutic drug monitoring 157
Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method 155
Mass spectrometry in the pharmacokinetic studies of anticancer natural products 150
Therapeutic drug monitoring of palbociclib, ribociclib and letrozole in women with breast cancer by LC-MS 146
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring 140
The development of a matrix-assisted laser desorption/ionization (MALDI)-based analytical method for determination of irinotecan levels in human plasma: Preliminary results 137
Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring 134
Increased plasma imatinib exposure and toxicity in chronically treated GIST patients with SARS-CoV-2 infection: a case series 130
A fast and validated LC-MS/MS method to quantify lenvatinib in dried blood spot 115
Matrix-assisted laser desorption/ionization, nanostructure-assisted laser desorption/ionization and carbon nanohorns in the detection of antineoplastic drugs. 1. The cases of irinotecan, sunitinib and 6-alpha-hydroxy paclitaxel 87
Totale 5.241
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.972
article - articoli 14.972
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.944
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 18 5
2021/2022184 8 20 13 11 4 28 10 16 9 14 15 36
2022/2023185 25 22 3 26 32 17 0 9 28 4 13 6
2023/2024122 6 16 6 11 9 27 11 6 10 3 11 6
2024/2025905 1 79 40 36 77 52 30 83 44 44 146 273
2025/20263.503 216 218 461 457 379 150 639 313 377 207 86 0
Totale 5.241